Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Catherine Thieblemont

Showing results (1-10 of 358) with videos related to

Pageof 36
Sort By:
Hematology. American Society of Hematology. Education Program|December 10, 2017
Improved biological insight and influence on management in indolent lymphoma. Talk 3: update on nodal and splenic marginal zone lymphomaCatherine Thieblemont
Bulletin Du Cancer|June 30, 2015
[Ibrutinib: A new drug of B-cell malignancies]Catherine Thieblemont
Hematology. American Society of Hematology. Education Program|November 24, 2005
Clinical presentation and management of marginal zone lymphomasCatherine Thieblemont
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 10, 2007
Lymphoma in older patientsCatherine Thieblemont, Bertrand Coiffier
International Journal of Hematology|January 7, 2003
Combination of chemotherapy and monoclonal antibodies for the treatment of lymphomaCatherine Thieblemont, Bertrand Coiffier
Blood|March 23, 2013
MYC, BCL2, BCL6 in DLBCL: impact for clinics in the future?Catherine Thieblemont, Josette Brière
Bulletin Du Cancer|February 3, 2021
[New European Approvals: Brexucabtagene autoleucel for refractory mantle cell lymphoma after Bruton tyrosine kinase (BTK) inhibitor]Adrien Rousseau, Catherine Thieblemont
Best Practice & Research. Clinical Haematology|March 15, 2017
Clinical aspects and therapy of gastrointestinal MALT lymphomaCatherine Thieblemont, Emanuele Zucca
La Revue Du Praticien|March 14, 2012
[The risk of lymphoma in Sjögren's syndrome]Catherine Thieblemont, Lionel Galicier
Current Oncology Reports|August 15, 2009
Second-line treatment paradigms for diffuse large B-cell lymphomasCatherine Thieblemont, Christian Gisselbrecht
Pageof 36

Showing results (1-10 of 358) with videos related to

Sort By:
Pageof 36
Hematology. American Society of Hematology. Education Program|December 10, 2017
Improved biological insight and influence on management in indolent lymphoma. Talk 3: update on nodal and splenic marginal zone lymphomaCatherine Thieblemont
Bulletin Du Cancer|June 30, 2015
[Ibrutinib: A new drug of B-cell malignancies]Catherine Thieblemont
Hematology. American Society of Hematology. Education Program|November 24, 2005
Clinical presentation and management of marginal zone lymphomasCatherine Thieblemont
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 10, 2007
Lymphoma in older patientsCatherine Thieblemont, Bertrand Coiffier
International Journal of Hematology|January 7, 2003
Combination of chemotherapy and monoclonal antibodies for the treatment of lymphomaCatherine Thieblemont, Bertrand Coiffier
Blood|March 23, 2013
MYC, BCL2, BCL6 in DLBCL: impact for clinics in the future?Catherine Thieblemont, Josette Brière
Bulletin Du Cancer|February 3, 2021
[New European Approvals: Brexucabtagene autoleucel for refractory mantle cell lymphoma after Bruton tyrosine kinase (BTK) inhibitor]Adrien Rousseau, Catherine Thieblemont
Best Practice & Research. Clinical Haematology|March 15, 2017
Clinical aspects and therapy of gastrointestinal MALT lymphomaCatherine Thieblemont, Emanuele Zucca
La Revue Du Praticien|March 14, 2012
[The risk of lymphoma in Sjögren's syndrome]Catherine Thieblemont, Lionel Galicier
Current Oncology Reports|August 15, 2009
Second-line treatment paradigms for diffuse large B-cell lymphomasCatherine Thieblemont, Christian Gisselbrecht
Pageof 36